Sweden · Venture startup

Who invested in Celluminova

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Medical Devices

Raised 5 months ago

Funding summaryUpdated 26 Oct 2026

$2.5Mraised across 2 rounds since 2020, from 2 sources

$406KVenture$2.1MVenture
Latest round
Venture, $2.1MJun 2026
Step-upi
5.2×
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2020202120222023202420252026
$406KVenture$2.1MVenture
First round
Venture, $406K
Jan 2020
Biggest round
$2.1M
Venture · Jun 2026
Between rounds
6.4 years
from the last two

The rounds

  1. Jun 2026
    Venture$2.1M1 returning

    Source recorded

  2. Jan 2020
    Venture$406K1 new

    Source recorded

Founders and team

From Celluminova's own website: 4 on the team.

  • Shirin IlkhanizadehChief Executive Officer
  • Marcus BäckChief Technology Officer
  • Cassandra StensMarket Development Lead
  • Eltjona RrapajResearch Scientist

Everyone who backed them

Almi InvestVC firm2rounds

Missing a round, or an investor who was in one? Tell us.

Quick answers about Celluminova

Who invested in Celluminova?

Celluminova's investors include Almi Invest.

How much has Celluminova raised?

Celluminova has raised $2.5M across 2 rounds since 2020.

When did Celluminova last raise?

Celluminova's most recent round was a Venture of $2.1M in Jun 2026.

What was Celluminova's biggest round?

Its most recent round, $2.1M in Jun 2026, is also its largest on record.

Who backed Celluminova first?

Celluminova's first round on record, in Jan 2020, was backed by Almi Invest.

What stage is Celluminova at?

Celluminova's latest named round is a Venture, in Jun 2026.

Where is Celluminova based?

Celluminova is based in Sweden.

Companies like Celluminova

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.